Related Experiment Videos
Low-grade lymphoma 1993: state of the art
1Stanford University Medical Center, Palo Alto, California.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
From spatial maps to treatment decisions: a roadmap for integrating explainable AI with multi-omics to guide precision immunotherapy.
Biotechnology notes (Amsterdam, Netherlands)·2026
Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.
Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Unveiling the Conundrum: Genital Tuberculosis with Omental Tubercles and Uterine Leiomyoma Masquerading as Malignancy.
International journal of applied & basic medical research·2026
Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.
Cancer pathogenesis and therapy·2026